ArticleOncology letters2026
Primary thoracic synovial sarcoma in a 45-year-old male: A case report and literature review.
Article in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synovial sarcoma (SS), a rare soft tissue cancer, develops at various body sites, with a predominant occurrence in the limbs. This report presents a rare case of primary thoracic SS (PTSS) in a 45-year-old male patient, characterized by chronic cough and occasional shortness of breath. Imaging examination revealed a substantial tumor mass in the left thoracic cavity. Although preoperative biopsy misdiagnosed the tumor as a solitary fibrous tumor, postoperative molecular analysis revealed that the tumor was SS based on the characteristic t(X;18)(p11.2;q11.2) translocation. The precise origin of the tumor within the thoracic cavity remained unclear, and the involvement of the pleura, chest wall and mediastinum was considered. The patient underwent surgical resection of the tumor followed by adjuvant chemotherapy with doxorubicin and nedaplatin. Regrettably, the patient showed widespread metastatic progression 8 months post-surgery and died 18 months thereafter because of tumor dissemination and associated complications. This case highlights the diagnostic challenges of PTSS and underscores the need for increased clinical awareness of rare thoracic tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.